Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel

Surgery for Obesity and Related Diseases

Volumn 3, Issue 4, 2007, Pages 443-445

  Caruana, Joseph A ^a   McCabe, Marc N ^a   Smith, Audrey D ^a   Panemanglore, Vishnudas Pai ^a   Sette Camara, Daniel ^a  

^a SISTERS OF CHARITY HOSPITAL   (United States)

Author keywords

Clopidogrel; Gastric bypass; Upper gastrointestinal bleeding

Indexed keywords

CLOPIDOGREL; FAMOTIDINE; PROTON PUMP INHIBITOR; WARFARIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DRUG WITHDRAWAL; EMERGENCY CARE; ENDOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; JEJUNUM ULCER; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH BYPASS; TREATMENT RESPONSE;

ADULT; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC BYPASS; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; TICLOPIDINE;

EID: 34447316773     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2006.12.008     Document Type: Article

References (16)

1. Drenick E.J., Bale G.S., Seltzer F.S., and Johnson D.G. Excessive mortality and causes of death in morbidly obese men. JAMA 243 (1980) 443-445
2. Gillum R.F., Mussolino M.E., and Madans J.H. Body fat distribution, obesity, overweight and stroke incidence in women and men: the NHANES I epidemiologic follow-up study. Int J Obes 25 (2001) 628-638
3. Manson J.E., Colditz G.A., Stampfer M.J., et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322 (1990) 882-889
4. Rimm E.B., Stampfer M.J., Giovannucci E., et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 141 (1995) 1117-1127
5. Kelly R.V., Hsu A., Topol E., and Steinhubl S. The influence of body mass index on outcomes and the benefit of antiplatelet therapy following percutaneous coronary intervention. J Invasive Cardiol 18 (2006) 115-119
6. Diener H.C., Ringleb P.A., and Savi P. Clopidogrel for the secondary prevention of stroke. Expert Opin Pharmacother 6 (2005) 755-764
7. Harker L.A., Boissel J.P., Pilgrim A.J., Gent M., and CAPRIE Steering Committee and Investigators. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug Saf 21 (1999) 325-335
8. Chan F.K., Ching J.Y., Hung L.C., et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 352 (2005) 238-244
9. Liberopoulos E.N., Elisaf M.S., Tselepis A.D., et al. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?. Platelets 17 (2006) 1-6
10. Ng F.H., Wong S.Y., Chang C.M., et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 18 (2003) 443-449
11. Lecompte T., and Hardy J.F. Antiplatelet agents and perioperative bleeding. Can J Anaesth 53 (2006) S103-S112
12. Lopez-Jimenez F., Bhatia S., Collazo-Clavell M.L., Sarr M.G., and Somers V.K. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc 80 (2005) 1157-1162
13. Nguyen N.T., Rivers R., and Wolfe B.M. Early gastrointestinal hemorrhage after laparoscopic gastric bypass. Obes Surg 13 (2003) 62-65
14. Braley S.C., Nguyen N.T., and Wolfe B.M. Late gastrointestinal hemorrhage after gastric bypass. Obes Surg 12 (2002) 404-407
15. Chan F.K., Chung S.C., Suen B.Y., et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344 (2001) 967-973
16. Fork F.T., Lafolie P., Toth E., and Lindgarde F. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers: a gastroscopic study. Scand J Gastroenterol 35 (2000) 464-469